The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Adult and Pediatric Vaccines Market Research Report 2025
Synopsis
A vaccine is a biological preparation that provides active acquired immunity to a particular disease.
The global Adult and Pediatric Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Adult and Pediatric Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adult and Pediatric Vaccines.
Report Scope
The Adult and Pediatric Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Adult and Pediatric Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adult and Pediatric Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Johnson and Johnson
Takeda Pharmaceutical
Bavarian Nordic
LG Life Sciences
Sinovac Biotech
Segment by Type
Adult Vaccines
Pediatric Vaccines
Segment by Application
Hospitals
Medical Care Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adult and Pediatric Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease.
The global Adult and Pediatric Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Adult and Pediatric Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adult and Pediatric Vaccines.
Report Scope
The Adult and Pediatric Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Adult and Pediatric Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adult and Pediatric Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Johnson and Johnson
Takeda Pharmaceutical
Bavarian Nordic
LG Life Sciences
Sinovac Biotech
Segment by Type
Adult Vaccines
Pediatric Vaccines
Segment by Application
Hospitals
Medical Care Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adult and Pediatric Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adult and Pediatric Vaccines Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Adult Vaccines
1.2.3 Pediatric Vaccines
1.3 Market by Application
1.3.1 Global Adult and Pediatric Vaccines Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Medical Care Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adult and Pediatric Vaccines Market Perspective (2019-2030)
2.2 Adult and Pediatric Vaccines Growth Trends by Region
2.2.1 Global Adult and Pediatric Vaccines Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Adult and Pediatric Vaccines Historic Market Size by Region (2019-2024)
2.2.3 Adult and Pediatric Vaccines Forecasted Market Size by Region (2025-2030)
2.3 Adult and Pediatric Vaccines Market Dynamics
2.3.1 Adult and Pediatric Vaccines Industry Trends
2.3.2 Adult and Pediatric Vaccines Market Drivers
2.3.3 Adult and Pediatric Vaccines Market Challenges
2.3.4 Adult and Pediatric Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adult and Pediatric Vaccines Players by Revenue
3.1.1 Global Top Adult and Pediatric Vaccines Players by Revenue (2019-2024)
3.1.2 Global Adult and Pediatric Vaccines Revenue Market Share by Players (2019-2024)
3.2 Global Adult and Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adult and Pediatric Vaccines Revenue
3.4 Global Adult and Pediatric Vaccines Market Concentration Ratio
3.4.1 Global Adult and Pediatric Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adult and Pediatric Vaccines Revenue in 2023
3.5 Adult and Pediatric Vaccines Key Players Head office and Area Served
3.6 Key Players Adult and Pediatric Vaccines Product Solution and Service
3.7 Date of Enter into Adult and Pediatric Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adult and Pediatric Vaccines Breakdown Data by Type
4.1 Global Adult and Pediatric Vaccines Historic Market Size by Type (2019-2024)
4.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Type (2025-2030)
5 Adult and Pediatric Vaccines Breakdown Data by Application
5.1 Global Adult and Pediatric Vaccines Historic Market Size by Application (2019-2024)
5.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Adult and Pediatric Vaccines Market Size (2019-2030)
6.2 North America Adult and Pediatric Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Adult and Pediatric Vaccines Market Size by Country (2019-2024)
6.4 North America Adult and Pediatric Vaccines Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adult and Pediatric Vaccines Market Size (2019-2030)
7.2 Europe Adult and Pediatric Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Adult and Pediatric Vaccines Market Size by Country (2019-2024)
7.4 Europe Adult and Pediatric Vaccines Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adult and Pediatric Vaccines Market Size (2019-2030)
8.2 Asia-Pacific Adult and Pediatric Vaccines Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2019-2024)
8.4 Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adult and Pediatric Vaccines Market Size (2019-2030)
9.2 Latin America Adult and Pediatric Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Adult and Pediatric Vaccines Market Size by Country (2019-2024)
9.4 Latin America Adult and Pediatric Vaccines Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adult and Pediatric Vaccines Market Size (2019-2030)
10.2 Middle East & Africa Adult and Pediatric Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2019-2024)
10.4 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Adult and Pediatric Vaccines Introduction
11.1.4 GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Adult and Pediatric Vaccines Introduction
11.2.4 Sanofi Revenue in Adult and Pediatric Vaccines Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Adult and Pediatric Vaccines Introduction
11.3.4 Merck Revenue in Adult and Pediatric Vaccines Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Adult and Pediatric Vaccines Introduction
11.4.4 Novartis Revenue in Adult and Pediatric Vaccines Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Adult and Pediatric Vaccines Introduction
11.5.4 Pfizer Revenue in Adult and Pediatric Vaccines Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Adult and Pediatric Vaccines Introduction
11.6.4 AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Johnson and Johnson
11.7.1 Johnson and Johnson Company Detail
11.7.2 Johnson and Johnson Business Overview
11.7.3 Johnson and Johnson Adult and Pediatric Vaccines Introduction
11.7.4 Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2019-2024)
11.7.5 Johnson and Johnson Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Detail
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Adult and Pediatric Vaccines Introduction
11.8.4 Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2019-2024)
11.8.5 Takeda Pharmaceutical Recent Development
11.9 Bavarian Nordic
11.9.1 Bavarian Nordic Company Detail
11.9.2 Bavarian Nordic Business Overview
11.9.3 Bavarian Nordic Adult and Pediatric Vaccines Introduction
11.9.4 Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2019-2024)
11.9.5 Bavarian Nordic Recent Development
11.10 LG Life Sciences
11.10.1 LG Life Sciences Company Detail
11.10.2 LG Life Sciences Business Overview
11.10.3 LG Life Sciences Adult and Pediatric Vaccines Introduction
11.10.4 LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2019-2024)
11.10.5 LG Life Sciences Recent Development
11.11 Sinovac Biotech
11.11.1 Sinovac Biotech Company Detail
11.11.2 Sinovac Biotech Business Overview
11.11.3 Sinovac Biotech Adult and Pediatric Vaccines Introduction
11.11.4 Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2019-2024)
11.11.5 Sinovac Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Adult and Pediatric Vaccines Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Adult Vaccines
Table 3. Key Players of Pediatric Vaccines
Table 4. Global Adult and Pediatric Vaccines Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Adult and Pediatric Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Adult and Pediatric Vaccines Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Adult and Pediatric Vaccines Market Share by Region (2019-2024)
Table 8. Global Adult and Pediatric Vaccines Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Adult and Pediatric Vaccines Market Share by Region (2025-2030)
Table 10. Adult and Pediatric Vaccines Market Trends
Table 11. Adult and Pediatric Vaccines Market Drivers
Table 12. Adult and Pediatric Vaccines Market Challenges
Table 13. Adult and Pediatric Vaccines Market Restraints
Table 14. Global Adult and Pediatric Vaccines Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Adult and Pediatric Vaccines Market Share by Players (2019-2024)
Table 16. Global Top Adult and Pediatric Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult and Pediatric Vaccines as of 2023)
Table 17. Ranking of Global Top Adult and Pediatric Vaccines Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Adult and Pediatric Vaccines Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Adult and Pediatric Vaccines Product Solution and Service
Table 21. Date of Enter into Adult and Pediatric Vaccines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Adult and Pediatric Vaccines Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Adult and Pediatric Vaccines Revenue Market Share by Type (2019-2024)
Table 25. Global Adult and Pediatric Vaccines Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Adult and Pediatric Vaccines Revenue Market Share by Type (2025-2030)
Table 27. Global Adult and Pediatric Vaccines Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Adult and Pediatric Vaccines Revenue Market Share by Application (2019-2024)
Table 29. Global Adult and Pediatric Vaccines Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Adult and Pediatric Vaccines Revenue Market Share by Application (2025-2030)
Table 31. North America Adult and Pediatric Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Adult and Pediatric Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Adult and Pediatric Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Adult and Pediatric Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Adult and Pediatric Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Adult and Pediatric Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Adult and Pediatric Vaccines Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Adult and Pediatric Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Adult and Pediatric Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Adult and Pediatric Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Adult and Pediatric Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 46. GlaxoSmithKline Company Detail
Table 47. GlaxoSmithKline Business Overview
Table 48. GlaxoSmithKline Adult and Pediatric Vaccines Product
Table 49. GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2019-2024) & (US$ Million)
Table 50. GlaxoSmithKline Recent Development
Table 51. Sanofi Company Detail
Table 52. Sanofi Business Overview
Table 53. Sanofi Adult and Pediatric Vaccines Product
Table 54. Sanofi Revenue in Adult and Pediatric Vaccines Business (2019-2024) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Merck Company Detail
Table 57. Merck Business Overview
Table 58. Merck Adult and Pediatric Vaccines Product
Table 59. Merck Revenue in Adult and Pediatric Vaccines Business (2019-2024) & (US$ Million)
Table 60. Merck Recent Development
Table 61. Novartis Company Detail
Table 62. Novartis Business Overview
Table 63. Novartis Adult and Pediatric Vaccines Product
Table 64. Novartis Revenue in Adult and Pediatric Vaccines Business (2019-2024) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Adult and Pediatric Vaccines Product
Table 69. Pfizer Revenue in Adult and Pediatric Vaccines Business (2019-2024) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. AstraZeneca Company Detail
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Adult and Pediatric Vaccines Product
Table 74. AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2019-2024) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. Johnson and Johnson Company Detail
Table 77. Johnson and Johnson Business Overview
Table 78. Johnson and Johnson Adult and Pediatric Vaccines Product
Table 79. Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2019-2024) & (US$ Million)
Table 80. Johnson and Johnson Recent Development
Table 81. Takeda Pharmaceutical Company Detail
Table 82. Takeda Pharmaceutical Business Overview
Table 83. Takeda Pharmaceutical Adult and Pediatric Vaccines Product
Table 84. Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2019-2024) & (US$ Million)
Table 85. Takeda Pharmaceutical Recent Development
Table 86. Bavarian Nordic Company Detail
Table 87. Bavarian Nordic Business Overview
Table 88. Bavarian Nordic Adult and Pediatric Vaccines Product
Table 89. Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2019-2024) & (US$ Million)
Table 90. Bavarian Nordic Recent Development
Table 91. LG Life Sciences Company Detail
Table 92. LG Life Sciences Business Overview
Table 93. LG Life Sciences Adult and Pediatric Vaccines Product
Table 94. LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2019-2024) & (US$ Million)
Table 95. LG Life Sciences Recent Development
Table 96. Sinovac Biotech Company Detail
Table 97. Sinovac Biotech Business Overview
Table 98. Sinovac Biotech Adult and Pediatric Vaccines Product
Table 99. Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2019-2024) & (US$ Million)
Table 100. Sinovac Biotech Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adult and Pediatric Vaccines Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Adult and Pediatric Vaccines Market Share by Type: 2023 VS 2030
Figure 3. Adult Vaccines Features
Figure 4. Pediatric Vaccines Features
Figure 5. Global Adult and Pediatric Vaccines Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Adult and Pediatric Vaccines Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Medical Care Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Adult and Pediatric Vaccines Report Years Considered
Figure 11. Global Adult and Pediatric Vaccines Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Adult and Pediatric Vaccines Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Adult and Pediatric Vaccines Market Share by Region: 2023 VS 2030
Figure 14. Global Adult and Pediatric Vaccines Market Share by Players in 2023
Figure 15. Global Top Adult and Pediatric Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult and Pediatric Vaccines as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Adult and Pediatric Vaccines Revenue in 2023
Figure 17. North America Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Adult and Pediatric Vaccines Market Share by Country (2019-2030)
Figure 19. United States Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Adult and Pediatric Vaccines Market Share by Country (2019-2030)
Figure 23. Germany Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Adult and Pediatric Vaccines Market Share by Region (2019-2030)
Figure 31. China Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Adult and Pediatric Vaccines Market Share by Country (2019-2030)
Figure 39. Mexico Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Adult and Pediatric Vaccines Market Share by Country (2019-2030)
Figure 43. Turkey Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Adult and Pediatric Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. GlaxoSmithKline Revenue Growth Rate in Adult and Pediatric Vaccines Business (2019-2024)
Figure 46. Sanofi Revenue Growth Rate in Adult and Pediatric Vaccines Business (2019-2024)
Figure 47. Merck Revenue Growth Rate in Adult and Pediatric Vaccines Business (2019-2024)
Figure 48. Novartis Revenue Growth Rate in Adult and Pediatric Vaccines Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Adult and Pediatric Vaccines Business (2019-2024)
Figure 50. AstraZeneca Revenue Growth Rate in Adult and Pediatric Vaccines Business (2019-2024)
Figure 51. Johnson and Johnson Revenue Growth Rate in Adult and Pediatric Vaccines Business (2019-2024)
Figure 52. Takeda Pharmaceutical Revenue Growth Rate in Adult and Pediatric Vaccines Business (2019-2024)
Figure 53. Bavarian Nordic Revenue Growth Rate in Adult and Pediatric Vaccines Business (2019-2024)
Figure 54. LG Life Sciences Revenue Growth Rate in Adult and Pediatric Vaccines Business (2019-2024)
Figure 55. Sinovac Biotech Revenue Growth Rate in Adult and Pediatric Vaccines Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
